NCT05110014

Brief Summary

This is a sub-study for data analysis of data collected as part of the larger randomized controlled trial "Effectiveness and Implementation of mPATH-CRC" (NCT03843957) to determine if self-administered screening with an iPad increases the detection of patients with depression, falls, and intimate partner violence.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23,026

participants targeted

Target at P75+ for not_applicable depression

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 24, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

October 26, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 5, 2021

Completed
5 months until next milestone

Results Posted

Study results publicly available

April 5, 2022

Completed
Last Updated

April 13, 2023

Status Verified

February 1, 2022

Enrollment Period

8 months

First QC Date

October 26, 2021

Results QC Date

December 23, 2021

Last Update Submit

March 17, 2023

Conditions

Keywords

Fall riskIntimate partner violence

Outcome Measures

Primary Outcomes (2)

  • Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Pre mPATH Use

    The primary outcome will be the proportion of patients seen in each time period ("pre" vs. "post") who screen positive for depression, fall risk, or intimate partner violence. The "pre" time period will be Days -60 to -1 (the 60 day period before mPATH Launch). Screening positive for depression will be a score of 3 or greater on the Patient Health Questionnaire-2. Screening positive for fall risk will be answering "yes" to having a device to assist with mobility and/or having fallen in the last year. Screening positive for intimate partner violence will be answering yes to any of the health system's three questions about safety in the home.

    2 months prior to use of intervention

  • Number of Participants Screening Positive for Depression, Fall Risk or Intimate Partner Violence - Post mPATH Use

    The primary outcome will be the proportion of patients seen in each time period ("pre" vs. "post") who screen positive for depression, fall risk, or intimate partner violence. The "post" time period will be days 14 to 73 (the 60 day period commencing 2 weeks after mPATH Launch). Screening positive for depression will be a score of 3 or greater on the Patient Health Questionnaire-2. Screening positive for fall risk will be answering "yes" to having a device to assist with mobility and/or having fallen in the last year. Screening positive for intimate partner violence will be answering yes to any of the health system's three questions about safety in the home.

    2 months after use of intervention

Secondary Outcomes (7)

  • Number of Participants Screening Positive for Depression Using Patient Health Questionnaires (PHQ-2 Score of 3 or Greater)

    2 months before and 2 months after using intervention

  • Number of Participants Screening Positive for Moderately Severe or Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 14)

    2 months before and 2 months after using intervention

  • Number of Participants Screening Positive for Severe Depression Using Patient Health Questionnaires (PHQ-9 Score Greater Than 19)

    2 months before and 2 months after using intervention

  • Number of Participants With a Patient Health Questionnaires (PHQ-9 Score Greater Than 14) and Not Currently Taking a Medication for Depression.

    2 months before and 2 months after using intervention

  • Number of Participants Who Report Thoughts of Self Harm - Patient Health Questionnaire (PHQ-9) in All Practices

    2 months before and 2 months after using intervention

  • +2 more secondary outcomes

Study Arms (1)

Primary Care Office Visits

OTHER

The limited use dataset will contain the following data elements for each completed patient visit: * Date of clinic visit (where each date is indicated by a number relative to the clinic's Launch Date) * Clinic (designated by a unique study clinic identifier) * Type of visit completed (for example, new patient visit, return patient visit, annual exam) * Patient age * Patient gender * Patient race/ethnicity * Patient primary insurance * Nursing staff who roomed the patient (designated by a unique study identifier) * Whether patient used mPATH-CheckIn program (Y/N) * Whether nursing staff used mPATH Nursing Module to transmit mPATH data to electronic health record (Y/N) * Whether patient has a diagnosis of depression in the problem list in the EHR (Y/N) * Whether patient has an antidepressant medication listed in the active medication list ( (Y/N) * Results of depression screening items * Results of fall risk screening items * Results of safety at home screening items

Other: Primary Care Office Visits

Interventions

mPATH iPad program that contains self-administered screening items for depression, fall risk, and intimate partner violence

Primary Care Office Visits

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Completed a provider visit at the study clinic during the 60 days prior to the clinic launching the mPATH program (the "pre" time period), or completed a provider visit at the study clinic during days 14 - 73 after the launch of mPATH (the "post" time period)
  • Have a preferred language of English or Spanish

You may not qualify if:

  • Requiring a language interpreter for a language other than Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Study Coordinator
Organization
Wake Forest Baptist Health Sciences

Study Officials

  • David Miller, MD, MS

    Wake Forest Baptist Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2021

First Posted

November 5, 2021

Study Start

June 24, 2019

Primary Completion

February 27, 2020

Study Completion

February 27, 2020

Last Updated

April 13, 2023

Results First Posted

April 5, 2022

Record last verified: 2022-02

Locations